Fifth Circuit tosses $340 million jury award against Becton Dickinson

An appellate court ruled on Friday that a company accused of infringing a rival’s patent on a safety syringe did not violate federal antitrust law because patent infringement is procompetitive.

Unlock unlimited access to all Global Competition Review content